ALIM Insider Trading

Insider Ownership Percentage: 31.40%
Insider Buying (Last 12 Months): $1,962,810.00
Insider Selling (Last 12 Months): $0.00

Alimera Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at Alimera Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alimera Sciences Share Price & Price History

Current Price: $3.20
Price Change: Price Decrease of -0.08 (-2.44%)
As of 05/17/2024 01:00 AM ET

This chart shows the closing price history over time for ALIM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alimera Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2023Caligan Partners LpMajor ShareholderBuy579,000$3.39$1,962,810.0016,835,154View SEC Filing Icon  
5/17/2023Adam MorganDirectorBuy1,401,901$1.70$2,383,231.701,659,654View SEC Filing Icon  
3/24/2023Alto Investors Lp PaloMajor ShareholderSell200,919$1.56$313,433.64View SEC Filing Icon  
2/8/2022Stanley MorganMajor ShareholderSell250,000$4.55$1,137,500.00View SEC Filing Icon  
12/15/2021Richard S. Eiswirth, Jr.CEOBuy484$4.50$2,178.00View SEC Filing Icon  
12/2/2021Richard S. Eiswirth, Jr.CEOBuy5,000$4.89$24,450.00View SEC Filing Icon  
11/5/2021Richard S. Eiswirth, Jr.CEOBuy1,400$5.50$7,700.00View SEC Filing Icon  
11/3/2021James R. LargentDirectorBuy10,000$4.31$43,100.00View SEC Filing Icon  
11/3/2021John Philip JonesCFOBuy5,000$4.08$20,400.00View SEC Filing Icon  
11/3/2021Richard S. Eiswirth, Jr.CEOBuy28,005$4.45$124,622.25View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alimera Sciences (NASDAQ:ALIM)

99.83% of Alimera Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALIM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alimera Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2024Ancora Advisors LLC234,620$0.92M0.0%N/A0.448%Search for SEC Filing on Google Icon
5/11/2024Hillsdale Investment Management Inc.43,400$0.17M0.0%N/A0.083%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,045,460$4.08M0.0%+61.1%1.996%Search for SEC Filing on Google Icon
5/2/2024Fifth Lane Capital LP21,238$83K0.1%N/A0.041%Search for SEC Filing on Google Icon
2/13/2024Stonepine Capital Management LLC3,999,459$17.28M7.5%+0.4%7.630%Search for SEC Filing on Google Icon
2/12/2024AIGH Capital Management LLC2,226,068$9.62M3.8%-6.2%4.247%Search for SEC Filing on Google Icon
2/9/2024Worth Venture Partners LLC556,642$2.41M1.3%-6.2%1.062%Search for SEC Filing on Google Icon
11/15/2023Worth Venture Partners LLC593,709$1.84M1.1%N/A1.133%Search for SEC Filing on Google Icon
11/14/2023Stonepine Capital Management LLC3,983,686$12.35M4.1%N/A7.600%Search for SEC Filing on Google Icon
11/13/2023AIGH Capital Management LLC2,372,572$7.36M3.5%N/A4.526%Search for SEC Filing on Google Icon
8/14/2023Perritt Capital Management Inc.10,000$29K0.0%-44.4%0.114%Search for SEC Filing on Google Icon
8/11/2023Velan Capital Investment Management LP1,659,654$4.85M4.5%+543.9%18.838%Search for SEC Filing on Google Icon
2/16/2023Caligan Partners LP478,777$1.30M1.0%N/A6.840%Search for SEC Filing on Google Icon
11/15/2022Perritt Capital Management Inc.18,000$91K0.1%-34.3%0.257%Search for SEC Filing on Google Icon
5/12/2022Healthcare of Ontario Pension Plan Trust Fund250,000$1.40M0.0%N/A3.575%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC497,639$2.55M0.8%-0.7%7.173%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc19,151$81K0.0%N/A0.276%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC141,588$0.60M0.0%-1.9%2.041%Search for SEC Filing on Google Icon
10/22/2021Optimum Investment Advisors8,108$34K0.0%+170.3%0.117%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP13,086$0.12M0.0%-50.6%0.189%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC38,300$0.35M0.0%+6.5%0.554%Search for SEC Filing on Google Icon
8/16/2021PDT Partners LLC17,723$0.16M0.0%+50.2%0.256%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley428,109$3.90M0.0%+0.7%6.190%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP30,842$0.28M0.2%+17.1%0.446%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP13,086$0.12M0.0%-50.6%0.189%Search for SEC Filing on Google Icon
8/13/2021Knott David M38,226$0.35M0.1%-34.2%0.553%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC25,091$0.23M0.0%+14.7%0.363%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.146,863$1.34M0.0%+16.6%2.124%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP28,570$0.26M0.0%N/A0.413%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG57,368$0.52M0.0%+51.0%0.829%Search for SEC Filing on Google Icon
8/2/2021Optimum Investment Advisors3,000$27K0.0%N/A0.043%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC10,402$100K0.0%N/A0.150%Search for SEC Filing on Google Icon
5/19/2021Diametric Capital LP26,328$0.25M0.2%N/A0.381%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley425,312$4.09M0.0%+1.1%6.150%Search for SEC Filing on Google Icon
5/18/2021Perritt Capital Management Inc.20,000$0.19M0.1%N/A0.289%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC10,402$100K0.0%N/A0.150%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC11,800$0.11M0.0%N/A0.171%Search for SEC Filing on Google Icon
5/14/2021Cooper Creek Partners Management LLC38,197$0.37M0.1%N/A0.552%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC145,213$1.40M0.0%-12.1%2.100%Search for SEC Filing on Google Icon
5/13/2021Knott David M58,108$0.56M0.2%-27.5%0.840%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC21,872$0.21M0.0%+57.3%0.316%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC16,950$0.16M0.0%+86.8%0.246%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC165,207$0.70M0.0%+39.3%3.219%Search for SEC Filing on Google Icon
12/30/2020Deerfield Management Company L.P. Series C68,413$0.33M0.0%N/A1.333%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alimera Sciences logo
Alimera Sciences, Inc., a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals. It operates through United States, International, and Operating Cost segments. The company offers ILUVIEN, a fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). It also provides YUTIQ, a fluocinolone acetonide intravitreal implant to treat NIU-PS. The company sells its products to physician offices, clinics, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. to develop, manufacture, and sell products including YUTIQ for the treatment and prevention of uveitis; and Ocumension (Hong Kong) Limited for the development and commercialization of the company's 190 microgram fluocinolone acetonide intravitreal implant in applicator for the treatment and prevention of eye diseases. Alimera Sciences, Inc. was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Read More on Alimera Sciences

Today's Range

Now: $3.20
Low: $3.18
High: $3.36

50 Day Range

MA: $3.69
Low: $3.20
High: $4.21

52 Week Range

Now: $3.20
Low: $2.10
High: $4.38

Volume

43,487 shs

Average Volume

51,295 shs

Market Capitalization

$167.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Alimera Sciences?

Alimera Sciences' top insider investors include:
  1. Caligan Partners Lp (Major Shareholder)
  2. Adam Morgan (Director)
  3. Alto Investors Lp Palo (Major Shareholder)
Learn More about top insider investors at Alimera Sciences.

Who are the major institutional investors of Alimera Sciences?

Alimera Sciences' top institutional investors include:
  1. Vanguard Group Inc. — 2.00%
  2. Ancora Advisors LLC — 0.45%
  3. Hillsdale Investment Management Inc. — 0.08%
  4. Fifth Lane Capital LP — 0.04%
  5. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Alimera Sciences stock.

Which major investors are buying Alimera Sciences stock?

During the previous quarter, ALIM stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. Ancora Advisors LLC
  3. Hillsdale Investment Management Inc.
  4. Fifth Lane Capital LP
During the previous year, these company insiders have bought Alimera Sciences stock:
  1. Caligan Partners Lp (Major Shareholder)
  2. Adam Morgan (Director)
Learn More investors buying Alimera Sciences stock.